Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Parkinson fatigue scale.

R G Brown1, A Dittner, L Findley

  • 1Department of Psychology, PO77, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. r.brown@iop.kcl.ac.uk

Parkinsonism & Related Disorders
|December 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pattern Formation in a Spatially Extended Model of Pacemaker Dynamics in Smooth Muscle Cells.

Bulletin of mathematical biology·2022
Same author

Chlorophyll fluorescence decay profiles of O<sub>3</sub> -exposed spruce needles as measured by time-correlated single photon counting.

The New phytologist·2021
Same author

Numerical Bifurcation Analysis of Pacemaker Dynamics in a Model of Smooth Muscle Cells.

Bulletin of mathematical biology·2020
Same author

Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

The role of nitric oxide in neurovascular coupling.

Journal of theoretical biology·2016
Same author

Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis.

Psychological medicine·2015
Same journal

Cerebellum crus II cortical thickness as a cognitive brain reserve in Parkinson's disease.

Parkinsonism & related disorders·2026
Same journal

Serious games and virtual reality in Parkinson's disease rehabilitation: A systematic review of randomized controlled trials.

Parkinsonism & related disorders·2026
Same journal

Respiratory-swallow training in Parkinson's disease: Effects of a single session on swallowing safety and efficiency with exploratory comparisons of biofeedback.

Parkinsonism & related disorders·2026
Same journal

Levodopa responsive childhood-onset generalized dystonia with diaphragmatic involvement associated with an SPTBN2 variant.

Parkinsonism & related disorders·2026
Same journal

Approach to a case of Neuro-Gonadal disorder: Perrault syndrome.

Parkinsonism & related disorders·2026
Same journal

Parakinesia in Chorea: Why attribution of intention is misleading.

Parkinsonism & related disorders·2026
See all related articles

A new Parkinson Fatigue Scale (PFS-16) was developed to measure fatigue in Parkinson's disease. This validated tool aids in understanding and managing fatigue, improving patient care and research.

Area of Science:

  • Neurology
  • Clinical Psychology

Background:

  • Fatigue is a significant and impactful symptom in Parkinson's disease.
  • Current assessment tools for fatigue lack validity in Parkinsonism.
  • Understanding and managing fatigue in Parkinson's disease requires a specific measurement instrument.

Purpose of the Study:

  • To introduce and validate the Parkinson Fatigue Scale (PFS-16).
  • To provide a reliable instrument for assessing fatigue in Parkinson's disease patients.
  • To facilitate clinical practice and research into Parkinson's disease fatigue.

Main Methods:

  • Development of a 16-item self-report scale (PFS-16) based on patient experiences.
  • Initial testing on nearly 500 Parkinson's patients, followed by validation on over 100 independent patients.

Related Experiment Videos

  • Psychometric evaluation including intrinsic properties, test-retest reliability, and associations with other fatigue measures.

    • Main Results:

    • The PFS-16 effectively measures the physical aspects of fatigue and their impact on daily function.
    • The scale demonstrates good psychometric properties and satisfactory test-retest reliability.
    • The PFS-16 accurately identifies patients with self-reported fatigue and those for whom it is a significant problem, with provided cut-off scores.

    Conclusions:

    • The PFS-16 is a valuable new instrument for assessing fatigue in Parkinson's disease.
    • Further evaluation is recommended, but the scale is ready for clinical practice and research.
    • The PFS-16 is expected to enhance the understanding and management of fatigue in Parkinson's disease.